Papillary thyroid carcinoma frequently metastasizes to regional lymph nodes, and lymph node metastasis increases the risk of local regional relapse. Recent evidence suggests that vascular endothelial growth factor-D (VEGF-D) promotes lymphangiogenesis, which in turn promotes lymphatic metastasis. Therefore, the role of VEGF-D messenger RNA transcript levels and VEGF-D immunoreactivity in lymph node metastasis in papillary thyroid carcinoma was investigated. In addition, the role of blood vascular vessel, lymph vessel, and Flt-4-positive vessel densities were studied in relation to their suspected association with lymph node metastasis, and with VEGF-D expression. VEGF-D messenger RNA transcript levels by quantitative real-time reverse transcription-polymerase chain reaction and VEGF-D immunoreactivity by immunohistochemistry in 49 papillary thyroid carcinomas were also studied. This was followed by quantitative immunohistochemical staining for CD34, podoplanin, and Flt-4. Lymph node metastasis was significantly correlated with VEGF-D messenger RNA transcript levels (P ¼ 0.027) and VEGF-D immunoreactivity (P ¼ 0.019). Increased lymph vessel density was also correlated with VEGF-D expression and lymph node metastasis. In conclusion, our findings indicate that VEGF-D expression and increased lymph vessel density may have an important role for lymph node metastasis in papillary thyroid carcinoma.
Papillary thyroid carcinoma metastasizes to regional lymph nodes at a high frequency. [1] [2] [3] In spite of the high incidence of nodal metastasis, the prognostic significance of lymph node metastasis remains controversial. It has also been reported that the presence of nodal metastasis had a significant impact on recurrence only in those patients older than 45 years. 4 Papillary thyroid carcinoma can metastasize via the blood stream or the lymphatic vasculature, but the mechanisms that determine the route of metastatic spread are largely unknown.
Vascular endothelial growth factor-D (VEGF-D, a novel VEGF member, has been found to induce not only angiogenesis but also lymphangiogenesis via VEGF receptor (VEGFR)-2 and VEGFR-3 (also known as Flt-4 5 ). Since VEGFR-3 has been demonstrated to be expressed almost exclusively in the lymphatic endothelium and thus considered to be a major regulator of lymphangiogenesis, 6 VEGF-D appears to be an important lymphangiogenic factor. Recent evidence suggests that tumor lymphangiogenesis, that is, the growth of tumor-associated lymphatic vessels, promotes lymphatic metastasis. 7 Our previous studies have also demonstrated that upregulated VEGF-D expression, and increased Flt-4-positive vessel density in human cancer were strongly correlated with lymph node metastasis and unfavorable prognosis. 8, 9 To evaluate the role of VEGF-D in tumor neovascularization and lymph node metastasis in papillary thyroid carcinoma, VEGF-D expression, and blood vessel density, lymph vessel density and Flt-4-positive vessel density were assessed in this study. Each microvessel density was studied to assess the growth of tumor-associated vessels. 10 To evaluate angiogenesis, CD34 expression, which is well known as a specific blood vascular endothelial marker, 11, 12 was used for the determination of blood vessel density. To evaluate lymphangiogenesis, podoplanin, a specific lymphatic endothelial marker, 13 was used for the determination of lymph vessel density. Finally, Flt-4-positive vessel density, which is expressed in lymphatic endothelium of normal tissues and also in blood vascular endothelium of malignant tumor tissues and granulation tissues, 6, 14 was evaluated for VEGF-D-effective vessel density. The relationship between VEGF-D expression and blood vessel density/lymph vessel density/Flt-4-positive vessel density as well as lymph node metastasis was also studied.
Materials and methods

Patients and Tumor Samples
The study included 49 patients with papillary thyroid carcinoma, diagnosed and treated in Kuma Hospital, Japan in 2003. All of these cases had no family history of thyroid cancer or malignancy in first-degree relatives as judged by interviews at the time of admission for surgery. The patients had received total or subtotal thyroidectomy with regional lymphadenectomy (central neck dissection, lateral neck dissection, superior mediastinal dissection, or a combination of the above).
All clinical charts and histopathology reports were reviewed for data regarding patient age, sex, tumor size, and presence or absence of lymph node metastasis or distant metastasis. All sections of the papillary thyroid carcinomas and presence or absence of lymph node metastasis were histologically evaluated by three pathologists (HY, YN, and KK). All 49 patients selected for analysis had classical papillary thyroid carcinomas on histopathology. Patients whose tumors showed tall cell or columnar cell differentiation or foci of insular or anaplastic dedifferentiation were not included. Patients with encapsulated papillary thyroid carcinomas or with multifocality were also excluded. Patients and tumor characteristics are shown in Table 1 . The median age at surgery for the 49 patients was 48.8 years (range, 16-76 years). In all, 59% of the patients were older than 45 years (n ¼ 29), and 79% (n ¼ 39) of the patients had lymph node metastasis at the time of surgery. A total of 15 cases or 31% of the patients had N1a lymph node metastasis. There was no correlation between pT and pN. All of the patients have been followed-up and none of the patients has had a recurrence.
Immunohistochemistry
For immunostainings, paraffin sections of 4-mm thickness were deparaffinized. They were then autoclaved for antigen retrieval, and followed by placing in a solution of 97% methanol and 3% hydrogen peroxide for 5 min. After washing in PBS, the slides were treated for 20 min with Protein Block Serum-free (DAKO Co, Carpinteria, CA, USA).
Primary antibodies were diluted as indicated in Table 2 with 0.3% BSA in PBS and incubated on the sections at 41C. After the overnight treatment with primary antibodies, to avoid the nonspecific biotin reaction, Histofine Simple Stain MAX PO (NICHIR-EI, Tokyo, Japan) was used as the second antibody for 60 min according to the manufacturer's instructions. Color was developed using diaminobenzidine with 0.01% hydrogen peroxide. Hematoxylin was used as a counterstain. For the negative control, all reagents except for the primary antibody were used.
Microscopic Assessment of VEGF-D Expression, Blood Vessel Density, Lymph Vessel Density, and Flt-4-Positive Vessel Density
The scoring and counts were performed blindly by three investigators who had no clinical knowledge of the patients and prognosis. Evaluation of VEGF-D immunoreactivity was performed according to White et al. 15 Grading of intensity and extent of staining of the malignant epithelium were as 16 The immunostained sections were scanned by light-microscopy at low magnification ( Â 4) and each of the areas of tissue with the greatest number of distinctly highlighted microvessels ('hot spots') were selected. Each microvessel density was then determined by counting all immunostained vessels at a total magnification of Â 200 from five areas for each case. The mean number of vessels in each case was evaluated. Since previous reports had suggested that different numbers of lymph vessels were present in intratumoral or peritumoral lesions in human malignant tumors, [17] [18] [19] a zonal analysis of the number of blood vessel density, lymph vessel density, or Flt-4-positive vessel density in intratumoral and peritumoral tissues was performed. Peritumoral microvessels were defined within an area of 100 mm from the tumor border. Intratumoral microvessels were defined within the tumor mass and not confined by invagination of normal tissue.
RNA Extraction and Reverse Transcription Reaction
Messenger RNA (mRNA) was extracted from fresh frozen tumor tissue samples using a QuickPrep micro mRNA purification kit (Amersham Biosciences, Buckinghamshire, UK) according to the protocol provided by the manufacturer. mRNA was reverse-transcribed for single-strand cDNA using Oligo-(dT) 20 primer and Thermoscript (Invitrogen, Tokyo, Japan). The reverse transcription (RT) reaction was performed at 551C for 60 min, followed by heating at 851C for 5 min. That only carcinoma tissue was included in freshly frozen thyroid tissue samples was ascertained by studying cryostat sections.
Quantitative Analysis of VEGF-D mRNA by Real-Time Polymerase Chain Reaction
Transcriptional levels of VEGF-D were measured by quantitative real-time polymerase chain reaction (PCR), similar to the method of Goydos and Gorski, 20 with some modifications. Assays were performed using universal TaqMan PCR reagents, and the reactions were recorded and analyzed using an ABI Prism 7000 sequence detector equipped with a 96-well thermal cycler (Perkin-Elmer Applied Biosystems, Foster City, CA, USA). 21 To analyze the ratio of gene transcript levels, we monitored the glyceraldehyde 3-phosphate dehydrogenase (GAPDH) transcripts as an internal control. The ratio of gene transcript levels of each sample (DCt) was evaluated on the basis of its GAPDH transcript content. All experiments were performed in triplicate, and the mean values were calculated (mean DCt). Inversed (DDCt) values were then used for statistical testing. The cDNA templates were subjected to a 5-min initial denaturation at 951C prior to 40 cycles of PCR (951C for 15 s and 601C for 1 min, per cycle). The primer and probe mixture for VEGF-D or GAPDH were purchased from Perkin-Elmer Applied Biosystems, and PCR was carried out according to the manufacturer's protocol.
Statistical Analysis
Mann-Whitney U-test was used to examine the association of lymph node metastasis with VEGF-D mRNA levels as well as each vessel density. Correlation of VEGF-D immunoreactivity with VEGF-D mRNA levels as well as each vessel density was also investigated by the Mann-Whitney U-test. Fisher's exact test was used to examine the association between lymph node metastasis and VEGF-D immunoreactivity. A P-value less than 0.05 was considered to be significant. A computer program package (StatView 5.0, Abacus Concepts, Barkeley, CA, USA) was used for all statistical testing and management of the database.
Results
Immunohistochemistry
Vessels positive for the blood vascular endothelial marker CD34 were observed in all papillary thyroid carcinoma (Figure 1a and c). They were identified in the endothelium of not only peritumoral vessels but also intratumoral vessels. Mean intratumoral blood vessel density was 170.6/each case, and mean peritumoral vessel density was 114.7/each case. Podoplanin-positive lymph vessels were present in all papillary thyroid carcinoma. All of the stained vessels were typically thin-walled and devoid of red blood cells. Consistent with previous reports, 22 most lymph vessels were detected in carcinomas with an invasive margin (Figure 1c) , and a few of these vessels were identified within the body of the carcinomas (data not shown). Mean intratumoral lymph vessel density was 4.6/each case, and mean peritumoral lymph vessel density was 13.6/each case. Flt-4-positive vessels were present in all papillary thyroid carcinoma. They were identified in the endothelium of not only peritumoral vessels but also intratumoral vessels (Figure 1b and e) . In peritumoral lesions, most of the Flt-4 expression was observed in the endothelium of podoplanin positive lymphatic vessels. On the other hand, in the intratumoral lesions most of the Flt-4 expression was identified in the endothelium of CD34-positive blood vessels. Mean intratumoral Flt-4-positive vessel density was 73.8/each case, and mean peritumoral Flt-4-positive vessel density was 25.9/each case. In papillary thyroid carcinoma cells, the cytoplasmic expression of VEGF-D protein was 
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H Yasuoka et al observed not only in the malignant (Figure 1f ) but also in the normal thyroid follicular cells (data not shown). The staining noted in the normal follicular epithelial cells was always of low grade (Grades 0-1), whereas in the tumor cells, the staining was both low and high grade (Grades 1-3) . For statistical analysis, VEGF-D antibody-stained sections were grouped as low grade (0-2) and high grade. 3 According to this criteria, high-grade VEGF-D expression was observed in 37% (18/49) of the 49 papillary thyroid carcinomas.
Statistics
The results are summarized in Tables 3 and 4 . As shown in Table 3 , a significant correlation was found between VEGF-D mRNA transcript levels or immunoreactivity and lymph node metastasis (P ¼ 0.027 and 0.019, respectively), and VEGF-D immunoreactivity tended to be correlated with VEGF-D transcript levels (P ¼ 0.059). VEGF-D immunoreactivity was significantly and positively associated with both intratumoral and peritumoral lymph vessel densities (P ¼ 0.011 and 0.046, respectively). No significant correlations were detected between VEGF-D immunoreactivity and blood vessel density (both intratumoral and peritumoral) or Flt-4-positive vessel density (both intratumoral and peritumoral). As shown in Table 4 , both intratumoral and peritumoral lymph vessel densities were significantly associated with lymph node metastasis (P ¼ 0.028 and 0.001, respectively). No significant correlations emerged between lymph node metastasis and blood or Flt-4-positive vessel density.
Discussion
Tumor metastasis may depend on the capacity of tumor cells to induce angiogenesis and/or lymphangiogenesis. VEGF-D, a potent angiogenic factor in vivo, which stimulates endothelial cell proliferation and migration, 5 is involved in promoting tumor angiogenesis and lymphangiogenesis.
7 VEGF-D is also known to be required for the growth and establishment of lymphatic vessels within tumors. However, the absence of specific markers for lymphatic vessels has made their identification difficult. Recently, podoplanin, an B38 kDa membrane mucoprotein originally detected on the surface of rat podocytes, 13 was established as a specific marker for lymphatic endothelium. 23 This discovery changed the landscape for lymphatic studies, with podoplanin being used as a valuable marker for identifying lymph vessels and accurately evaluating lymph vessel density. 17, 18, [24] [25] [26] In this study, we found that lymph node metastasis was statistically correlated with both increased lymph vessel density and VEGF-D expression of both mRNA and protein, and that VEGF-D immunoreactivity was significantly and positively correlated with increased lymph vessel density. Our study is the first to demonstrate that there was a significant correlation between VEGF-D expression and lymph vessel density, or between VEGF-D expression and lymph node metastasis, in human papillary thyroid carcinoma. These results concur with previous animal studies that VEGF-D plays an important role in lymph node metastasis via lymphangiogenesis. 7 An earlier report using human papillary thyroid carcinoma also supported our present observation that the presence of lymphatics in papillary thyroid carcinoma was significantly associated with nodal metastasis. 22 VEGF-D expression is upregulated in a number of other types of tumors. 8, 15 In this study, we found that increased VEGF-D expression was correlated with lymph node metastasis in papillary thyroid carcinoma. Tanaka et al, 27 however, were unable to find a significant relationship between VEGF-D expression and lymph node metastasis. As mentioned earlier, VEGF-D immunoreactivity can also be detected in normal thyroid follicular epithelium. We carefully confirmed that only carcinoma tissue was included in the freshly frozen thyroid tissue samples by viewing cryostat sections. Therefore, the RT-PCR assay used by Tanaka et al may not have revealed a true and specific expression of VEGF-D in tumor cells if a carefully conducted laser microdissection was not utilized to obtain only tumor cells for their analyses. Furthermore, Tanaka et al found VEGF-D expression in only about 52% of the tumor tissues investigated using a semiquantitative RT-PCR method. This consisted of electrophoresis in agarose gel, scanning the bands of the positive films and measuring the density and the width of each of the PCR products. As a result of the higher sensitivity of using real-time PCR to detect PCR transcripts, VEGF-D mRNA expression was detected in all papillary thyroid carcinomas in our study.
In conclusion, VEGF-D expression was correlated with increased lymph vessel density, and may have an important role for lymphangiogensis in papillary thyroid carcinoma. VEGF-D expression and increased lymph vessel density was also associated with lymph node metastasis, and may play an important role in the progression of lymph node metastasis.
